Harm-benefit Tradeoff

Harm-Benefit Tradeoff is a normative decision-making construct in risk-benefit assessment that evaluates the balance between potential harms and anticipated benefits by determining whether the magnitude or likelihood of adverse outcomes is ethically and pragmatically justifiable relative to the expected gains.

102

Publications

6.7K

Citations

400

Authors

257

Institutions

Publications per year

2017–2026

47

Authors

400

  1. NP
    Nora Pashayan

    University College London, United Kingdom

    5 publications · 583 citations

    5

    h-index

  2. ML
    Manuela L. Ferreira

    The University of Sydney, Australia

    4 publications · 178 citations

    4

    h-index

  3. PH
    Paulo H. Ferreira

    The University of Sydney, Australia

    3 publications · 157 citations

    3

    h-index

  4. JJ
    Jesse Jansen

    The University of Sydney, Australia

    3 publications · 1.6K citations

    3

    h-index

  5. KM
    Kirsten McCaffery

    The University of Sydney, Australia

    3 publications · 94 citations

    3

    h-index

1–5 of 400

Venues

  1. Medical Decision Making

    MDM · 4 publications · 285 citations

    4

    h-index

  2. Journal of Medical Ethics

    3 publications · 222 citations

    3

    h-index

  3. Journal of Clinical Epidemiology

    3 publications · 196 citations

    3

    h-index

  4. PLoS ONE

    3 publications · 235 citations

    3

    h-index

  5. BMC Public Health

    2 publications · 31 citations

    2

    h-index

1–5